Endonuclease V Variants for Thermostable DNA Cleavage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Endonuclease V enzymes from E. coli lack thermostability and stability under severe conditions, limiting their efficiency in high-temperature and high-salt processes without stabilizing agents.

Innovation Solution

Development of variants with specific amino acid substitutions such as C169Q, K133T, K138D, K155G, K194R, and D206H, which enhance thermostability, solubility, and residual activity, allowing for efficient cleavage of deoxyinosine-containing DNA even without reducing agents like BSA or TCEP.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Endonuclease V from E. coli is used under high temperature and high salt conditions, then the enzyme can perform cleavage activity, but the enzyme loses stability and residual activity

Engineering Contradiction:
Improveenzyme stabilityVSAvoidoperating temperature range
Core Design Contradiction:
ReliabilityVSTemperature

Solution Approach 1:

The patent applies parameter changes by modifying specific amino acid residues (C136, C169, C192, K133, K138, K155, K194, D206) in the enzyme sequence to alter its thermal and chemical stability properties, enabling it to maintain activity under harsh conditions without requiring stabilizing agents

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite enzyme system by combining multiple amino acid substitutions at different positions to achieve synergistic effects that improve both thermostability and residual activity simultaneously

Inventive Principle:
Principle #40Composite materials

2Reliability

If stabilizing agents such as BSA or reducing agents such as TCEP/DTT are added to maintain enzyme activity, then the enzyme retains residual activity under thermal stress, but the system complexity and cost increase

Engineering Contradiction:
Improveresidual activityVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The engineered enzyme variants perform self-service by inherently maintaining their own structural stability and catalytic activity under harsh conditions through their modified amino acid sequences, eliminating the need for external stabilizing agents like BSA or reducing agents

Inventive Principle:
Principle #25Self-service

3Productivity

If the enzyme is used for prolonged periods under non-reducing conditions, then the cleavage reaction can be sustained, but the enzyme activity decreases over time

Engineering Contradiction:
Improvecleavage reaction efficiencyVSAvoidenzyme longevity
Core Design Contradiction:
ProductivityVSDuration of action of stationary object

Solution Approach 1:

The patent modifies the enzyme's chemical parameters through amino acid substitutions that enhance its resistance to denaturation and inactivation under prolonged non-reducing conditions, thereby extending its operational lifespan and maintaining productivity over time

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The variants exhibit improved stability and cleavage kinetics, maintaining activity at elevated temperatures and reducing the need for stabilizing agents, thus enhancing the enzyme's performance in harsh conditions.

Implementation Method 1

Endonuclease V (herein after referred to as Endo V), also called deoxyinosine 3' endonuclease, is a DNA repair enzyme that recognizes DNA containing deoxyinosine (a deamination product of a deoxyadenosine, also referred to as inosine and hypoxanthine) residues. Endo V primarily cleaves the second and third phosphodiester bond 3' to an inosine residue in the same strand, leaving a nick with a 3'-hydroxyl and a 5'-phosphate.

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS20230416708A1Novel Variants of Endonuclease V and Uses Thereof
Publication Date: 2023.12.28 DNA SCRIPT SAS
  • US20230416708A1 patent drawing
  • US20230416708A1 patent drawing
  • US20230416708A1 patent drawing

AI summary

The present invention relates to novel polypeptides having an endonuclease V activity, and uses thereof.